Literature DB >> 32552452

Genotyping and molecular characterization of clinical Acinetobacter baumannii isolates from a single hospital in Southwestern Iran.

Ahmad Farajzadeh Sheikh1,2, Mohammad Savari1,2, Effat Abbasi Montazeri1,2, Saeed Khoshnood1,2.   

Abstract

ACINETOBACTER BAUMANNII: (A. baumannii) is a pathogen responsible for nosocomial infections among the hospitalized patients. The aim of this study was to investigate genotyping and molecular characterization and to examine the biofilm formation ability of A. baumannii isolates. In total, 70 A. baumannii isolates were collected from patients admitted to Imam Khomeini Hospital in Ahvaz, Southwestern Iran. Minimum inhibitory concentrations (MIC) test was performed using Vitek 2 system. The presence of genes encoding metallo-β-lactamases, oxacillinases, and integrase and the biofilm formation ability were then evaluated. Multiple locus variable-number tandem repeat (VNTR) analysis (MLVA) typing and multiplex PCR were performed to determine the genetic relationships. The blaOXA-23-like gene had the highest prevalence. The frequency of genes encoding bla SPM, bla IMP, and bla VIM among MDR A. baumannii isolates were 12 (17.1%), 18 (25.7%), and 22 (31.4%), respectively. Moreover, 46 isolates (75.4%) harbored class I integron and 10 isolates (16.39%) carried class II integron. The number of weak, moderate and strong biofilm-producing isolates were 3 (4.3%), 7 (10%), and 55 (78.5%), respectively. The results showed that 70 A. baumannii isolates were grouped into 12 distinct MLVA types with five clusters and four singleton genotypes. In addition, 25 (35.7%) isolates were assigned to international clone (IC) variants, 37 (52.8%) isolates belonged to group 1 (IC II), and 8  (11.4%) isolates belonged to group 2 (IC I). Our findings revealed that the population structure of the A. baumannii isolates was genetically diverse. More focus on genetic variation and antibiotic resistance of A. baumannii isolates are recommended.

Entities:  

Keywords:  Acinetobacter baumannii ; MLVA; drug resistance; integron; metallo-β-lactamase

Mesh:

Substances:

Year:  2020        PMID: 32552452      PMCID: PMC7480470          DOI: 10.1080/20477724.2020.1765124

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  54 in total

1.  Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion.

Authors:  Natacha Martins; Libera Dalla-Costa; Aline Almeida Uehara; Lee Woodland Riley; Beatriz Meurer Moreira
Journal:  Infect Genet Evol       Date:  2013-10-10       Impact factor: 3.342

2.  Global spread of carbapenem-resistant Acinetobacter baumannii.

Authors:  Paul G Higgins; Cathrin Dammhayn; Meredith Hackel; Harald Seifert
Journal:  J Antimicrob Chemother       Date:  2009-12-08       Impact factor: 5.790

3.  Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

Authors:  Ronald N Jones; Mary Jane Ferraro; L Barth Reller; Paul C Schreckenberger; Jana M Swenson; Helio S Sader
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

4.  High prevalence of extensively drug-resistant and metallo beta-lactamase-producing clinical Acinetobacter baumannii in Iran.

Authors:  Hossein Maspi; Hamideh Mahmoodzadeh Hosseini; Mohsen Amin; Abbas Ali Imani Fooladi
Journal:  Microb Pathog       Date:  2016-07-20       Impact factor: 3.738

5.  Detection of blaOXA-23-like and blaNDM-1 in Acinetobacter baumannii from the Eastern Region, Saudi Arabia.

Authors:  Taghrid S El-Mahdy; Mohamed H Al-Agamy; Ahmed A Al-Qahtani; Atef M Shibl
Journal:  Microb Drug Resist       Date:  2016-05-16       Impact factor: 3.431

6.  Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance.

Authors:  Prabhu Raj Joshi; Mahesh Acharya; Trishna Kakshapati; Udomluk Leungtongkam; Rapee Thummeepak; Sutthirat Sitthisak
Journal:  Antimicrob Resist Infect Control       Date:  2017-02-07       Impact factor: 4.887

7.  First report of OXA-143-lactamase producing Acinetobacter baumannii in Qom, Iran.

Authors:  Zohreh Sarikhani; Razieh Nazari; Mahmoud Nateghi Rostami
Journal:  Iran J Basic Med Sci       Date:  2017-11       Impact factor: 2.699

8.  Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.

Authors:  Abbas Bahador; Zahra Farshadzadeh; Reza Raoofian; Masoumeh Mokhtaran; Babak Pourakbari; Maryam Pourhajibagher; Farhad B Hashemi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-06-01       Impact factor: 3.944

9.  A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.

Authors:  Baris Boral; Özlem Unaldi; Alper Ergin; Riza Durmaz; Özgen Köseoğlu Eser
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-07-02       Impact factor: 3.944

10.  Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis.

Authors:  Maryam Pourhajibagher; Farhad B Hashemi; Babak Pourakbari; Masoud Aziemzadeh; Abbas Bahador
Journal:  Open Microbiol J       Date:  2016-03-29
View more
  1 in total

1.  A Comprehensive Study of the Relationship between the Production of β-Lactamase Enzymes and Iron/Siderophore Uptake Regulatory Genes in Clinical Isolates of Acinetobacter baumannii.

Authors:  Mahyar Porbaran; Hamed Tahmasebi; MohammadReza Arabestani
Journal:  Int J Microbiol       Date:  2021-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.